Poly Medicure Experiences Revision in Stock Evaluation Amid Market Fluctuations Poly Medicure, a prominent player in the Medical Equipment/Supplies/Accessories industry, has recently undergone a revision in its stock evaluation. The company, recognized as a large-cap entity, has demonstrated consistent performance and has been included in MarketsMOJO's list since August 7, 2023. On December 31, 2024, Poly Medicure's stock experienced a decline of 3.1%, underperforming the sector by 3.41%. This downturn follows a brief period of gains, indicating a trend reversal after two consecutive days of positive movement. The stock reached an intraday low of Rs 2580, reflecting a drop of 4.66% during the trading session. Despite these recent challenges, Poly Medicure continues to hold a position above its 5-day, 100-day, and 200-day moving averages, although it currently sits below its 20-day and 50-day moving averages. Over the past month, the stock has faced a decline of 7.09%, contrasting with the Sensex's performance of a 2.46% decrease. As the market landscape evolves, Poly Medicure remains a noteworthy entity within its sector.

Dec 31 2024 09:35 AM IST
share
Share Via
Poly Medicure has recently undergone a revision in its score, reflecting the stock's current market dynamics. Despite a decline in performance on December 31, 2024, the company remains a notable player in the medical equipment sector and has been added to MarketsMojo's list, highlighting its ongoing relevance in the industry.
Poly Medicure, a prominent player in the Medical Equipment/Supplies/Accessories industry, has recently experienced a revision in its stock evaluation. The company, which is classified as a large-cap entity, has been noted for its consistent performance and has been part of MarketsMOJO's list since August 7, 2023.

On December 31, 2024, Poly Medicure's stock saw a decline of 3.1%, underperforming the sector by 3.41%. This downturn follows a brief period of gains, marking a trend reversal after two consecutive days of positive movement. The stock reached an intraday low of Rs 2580, reflecting a drop of 4.66% during the trading session.

Despite the recent challenges, Poly Medicure maintains a position above its 5-day, 100-day, and 200-day moving averages, although it is currently below its 20-day and 50-day moving averages. Over the past month, the stock has faced a decline of 7.09%, contrasting with the Sensex's performance of a 2.46% decrease. As the market continues to evolve, Poly Medicure remains a noteworthy entity within its sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News